Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Technical transformation of biodefense vaccines.

Lu S, Wang S.

Vaccine. 2009 Nov 5;27 Suppl 4:D8-D15. doi: 10.1016/j.vaccine.2009.08.055. Review.

2.

Developing vaccines to counter bioterrorist threats.

Altmann DM.

Expert Rev Vaccines. 2005 Jun;4(3):275-9. Review.

PMID:
16026243
3.

DNA vaccines for biodefence.

Garmory HS, Perkins SD, Phillpotts RJ, Titball RW.

Adv Drug Deliv Rev. 2005 Jun 17;57(9):1343-61. Epub 2005 Apr 13. Review.

PMID:
15935877
4.

Introduction to this supplement.

Barrett AD, Lu S, Poland GA.

Vaccine. 2009 Nov 5;27 Suppl 4:D1. doi: 10.1016/j.vaccine.2009.09.053. No abstract available.

PMID:
19837278
5.

Making vaccines "on demand": a potential solution for emerging pathogens and biodefense?

De Groot AS, Einck L, Moise L, Chambers M, Ballantyne J, Malone RW, Ardito M, Martin W.

Hum Vaccin Immunother. 2013 Sep;9(9):1877-84. doi: 10.4161/hv.25611. Epub 2013 Jul 22. Review.

6.

Production of vaccines against leading biowarfare toxins can utilize DNA scientific technology.

Middlebrook JL.

Adv Drug Deliv Rev. 2005 Jun 17;57(9):1415-23. Review.

PMID:
15896873
7.

Current biodefense vaccine programs and challenges.

Wolfe DN, Florence W, Bryant P.

Hum Vaccin Immunother. 2013 Jul;9(7):1591-7. doi: 10.4161/hv.24063. Epub 2013 Feb 21.

PMID:
23428906
8.

Vaccine process technology.

Josefsberg JO, Buckland B.

Biotechnol Bioeng. 2012 Jun;109(6):1443-60. doi: 10.1002/bit.24493. Epub 2012 Mar 30. Review.

PMID:
22407777
9.

Agility in adversity: Vaccines on Demand.

De Groot AS, Moise L, Olive D, Einck L, Martin W.

Expert Rev Vaccines. 2016 Sep;15(9):1087-91. doi: 10.1080/14760584.2016.1205951. Epub 2016 Jul 18. Review.

PMID:
27389971
10.

[Progress of research on DNA vaccines against parasitosis].

Qi WJ, Fang Q.

Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi. 2011 Jun;23(3):340-4. Review. Chinese.

PMID:
22164511
11.

Approaches to new vaccines.

Mahon BP, Moore A, Johnson PA, Mills KH.

Crit Rev Biotechnol. 1998;18(4):257-82. Review.

PMID:
9887505
12.

Biotechnology in the development of new vaccines and diagnostic reagents against tuberculosis.

Mustafa AS.

Curr Pharm Biotechnol. 2001 Jun;2(2):157-73. Review.

PMID:
11480420
13.

Fully mobilizing host defense: building better vaccines.

Raychaudhuri S, Rock KL.

Nat Biotechnol. 1998 Nov;16(11):1025-31. Review.

PMID:
9831030
14.

Influenza vaccines: new developments.

Rimmelzwaan GF, Osterhaust AD.

Curr Opin Pharmacol. 2001 Oct;1(5):491-6. Review.

PMID:
11764775
15.

Vaccine presentations and delivery technologies--what does the future hold?

Clements CJ, Wesselingh SL.

Expert Rev Vaccines. 2005 Jun;4(3):281-7. Review.

PMID:
16026244
16.

Controlled delivery of antigens and adjuvants in vaccine development.

Zhao Z, Leong KW.

J Pharm Sci. 1996 Dec;85(12):1261-70. Review.

PMID:
8961136
17.

DNA vaccines: a review.

Lewis PJ, Babiuk LA.

Adv Virus Res. 1999;54:129-88. Review.

PMID:
10547676
18.

Recombinant vaccines for influenza virus.

Tripp RA, Tompkins SM.

Curr Opin Investig Drugs. 2008 Aug;9(8):836-45. Review.

PMID:
18666031
19.

Recent progress in the development and testing of vaccines against human tuberculosis.

McMurray DN.

Int J Parasitol. 2003 May;33(5-6):547-54. Review.

PMID:
12782054
20.

Bacterial ghosts as adjuvant particles.

Riedmann EM, Kyd JM, Cripps AW, Lubitz W.

Expert Rev Vaccines. 2007 Apr;6(2):241-53. Review.

PMID:
17408373

Supplemental Content

Support Center